For his profound contributions to cancer science and medicine throughout his impressive 25 years at the FDA, where he has led an era of progress that has improved outcomes for countless patients with cancer. This award celebrates the tremendous efforts of Pazdur and his team to expedite the development of novel cancer therapeutics and to establish integrated regulatory approaches that have enhanced the cross-center coordination of oncology product clinical reviews.